E-viri
Recenzirano
Odprti dostop
-
Bortoluzzi, P.; Ferrucci, S.; Galimberti, D.; Garavelli, F.; Pozzo Giuffrida, F.; Pizzati, A.; Marzano, A.V.; Mapelli, C.
British journal of dermatology (1951), January 2022, 2022-01-00, 2022-01-01, 20220101, Letnik: 186, Številka: 1Journal Article
Our study sought to describe ocular surface alterations at baseline and after 4 months of dupilumab treatment in patients with severe AD. Our findings highlight that all 25 patients showed ocular surface alterations prior to dupilumab treatment. Dupilumab may cause the worsening of clinical or subclinical pre‐existing ocular alterations belonging to the spectrum of AKC.
